ArticleJournal of cellular and molecular medicine2019

Lumiflavin increases the sensitivity of ovarian cancer stem-like cells to cisplatin by interfering with riboflavin.

Ruhui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.